Find the latest purple biotech ltd. Adr stock information by barron's.
Shares in purple biotech are currently priced at $4.45.
Purple biotech stock nyse. The price to earnings (p/e) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by. Nt219 is a small molecule targeting the novel cancer drug resistance pathways irs1/2 and stat3. The average ppbt stock price target is 25.00 with a high estimate of 25.00 and a low estimate of 25.00.
Earnings for purple biotech are expected to decrease in the coming year, from ($0.40) to ($0.50) per share. Its growth ranks better than 85% of the companies in biotechnology industry. (ppbt) stock quote, history, news and other vital information to help you with your stock trading and investing.
At that level they are trading at 5.55% discount to the analyst consensus target price of 0.00. Purple biotech currently has 1 buy rating from wall street analysts. If you are looking for the complete list of biotech stocks on the nasdaq, click here.
Our overall hedge fund sentiment score for ppbt is 62. The complete list of biotech and related stocks trading on the nyse as of dec 4, 2021 are shown below: Dive deeper with interactive charts and top stories of purple biotech ltd.
The new york stock exchange , nasdaq and cboe edgx exchange, inc. 1 wall street analysts have issued buy, hold, and sell ratings for purple biotech in the last twelve months. The stock has a consensus analyst rating of buy. a buy rating indicates that analysts believe ppbt will outperform the market and that investors should add to their positions of.
Purple biotech stock gives every indication of being modestly overvalued. No news for ppbt in the past two years. 10, 2021 at 12:07 p.m.
(nasdaq:ppbt) is not the most popular stock in this group but hedge fund interest is still above average. 9 things for investors to know about purple biotech as shares surge feb. Webull financial llc is a member of sipc, which protects securities customers of its members up to.
View the latest ppbt stock quote and chart on msn money. Adr research and ratings by barron's. Purple biotech to present at the jefferies london healthcare conference.
(purple biotech , or the company) (nasdaq/tase: 10 25 30 50 100. Purple biotech (nasdaq:ppbt) in the past three months, purple biotech insiders have not sold or bought any company stock.
Get the latest purple biotech stock price and detailed information including ppbt news, historical charts and realtime prices. There are currently 1 buy rating for the stock. The complete list of biotechnology stocks trading on the nyse.
Only 2.98% of the stock of purple biotech is held by insiders. Purple biotech does not have a long track record of dividend growth. Only 2.98% of the stock of purple biotech is held by insiders.
The company's financial condition is fair and its profitability is poor. Purple biotech does not currently pay a dividend. Only 30.72% of the stock of purple biotech is held by institutions.
The consensus among wall street analysts is that investors should buy purple biotech stock.
0 komentar:
Posting Komentar